| Serial Number | 98553736 |
| Word Mark | CONCORDIA RX |
| Filing Date | Thursday, May 16, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Sunday, December 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the words "CONCORDIA RX", wherein both terms share a common "R" and the "X" is formed by the rightmost leg of the "R" and a diagonal line crossing it. |
| Goods and Services | a full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids) |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 16, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, February 28, 2017 |
| First Use In Commerce Date | Tuesday, February 28, 2017 |
| Party Name | Concordia Pharmaceuticals Inc., S.à.r.L |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Luxembourg L-1610 LU |
| Event Date | Event Description |
| Thursday, May 16, 2024 | NEW APPLICATION ENTERED |
| Monday, November 18, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, November 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 2, 2024 | ASSIGNED TO EXAMINER |
| Sunday, December 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, December 22, 2024 | NON-FINAL ACTION WRITTEN |
| Sunday, December 22, 2024 | NON-FINAL ACTION E-MAILED |